PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Samaritan Pharmaceuticals

Press Release


Receive press releases from Samaritan Pharmaceuticals: By Email RSS Feeds:

Actors Studio's Anna Strasberg Joins Samaritan Advisory Board of Directors


Ms. Anna Strasberg has joined Samaritan's Advisory Board. Anna Strasberg is best known for continuing the Actors Studio, where the work of her husband Lee Strasberg nurtured the talents of celebrities like Marlon Brando, Robert De Niro, Harvey Keitel, Paul Newman and Al Pacino.

Las Vegas, NV, January 03, 2008 --(PR.com)-- Samaritan Pharmaceuticals Inc., a developer of innovative drugs (AMEX:LIV), is honored to announce that Ms. Anna Strasberg has joined Samaritan's Advisory Board. Anna Strasberg is best known for continuing the Actors Studio, where the work of her husband Lee Strasberg nurtured the talents of celebrities like Marlon Brando, Robert De Niro, Harvey Keitel, Paul Newman and Al Pacino.

Dr. Janet Greeson, CEO of Samaritan Pharmaceuticals stated, "Anna Strasberg offers Samaritan a unique networking opportunity with celebrities that have an interest in supporting innovative cures for life threatening diseases such as Alzheimer's, AIDS, and Hepatitis C, or an interest in helping children with HIV and rare diseases. She is a totally impressive woman and we are grateful she has joined our team to make a difference.''

Ms. Strasberg came to America from Venezuela in 1960 and began working at the United Nations as Special Assistant to Jeff Sparks in the Cultural Department, working directly under the supervision of Mrs. Eleanor Roosevelt. Interested in theatre, Anna worked off-off-Broadway with the Washington Players Theatre. She also worked in television and films. Ms. Strasberg met and married the legendary director, actor and master teacher Mr. Lee Strasberg of the Actors Studio in 1967. Representing the United States, Mr. and Mrs. Strasberg traveled for the State Department to Germany, Russia, Buenos Aires and Italy. Today, Ms. Strasberg continues the work of The Lee Strasberg Theatre and Film Institutes in New York and Los Angeles. She founded, and is the Artistic Director of, The Lee Strasberg Creative Center, a nonprofit organization through which scholarships in acting, writing and directing are given yearly to talented and deserving young artists of the inner city. Scholarships to study at The Lee Strasberg Theatre and Film Institute have also been awarded to disadvantaged students from the United World College of The Atlantic in Wales, where Mrs. Strasberg has also lectured. She has also received the Nosotros Award for pioneering programs to develop the talents of Hispanic actors and playwrights.

Samaritan Pharmaceuticals:
"Transforming Today's Science Into Tomorrow's Cures...''
Samaritan Pharmaceuticals is a life science company focused on commercializing its pipeline of innovative drugs to relieve the suffering of patients with Alzheimer's, cancer, heart disease, and infectious disease. Samaritan's business strategy is to partner drug candidates in its pipeline after Phase II (proof of concept) human studies. Samaritan has executed its first partnering agreement with Pharmaplaz, Ireland for its PII, HIV drug SP-01A. In addition, Samaritan's sales arm has acquired the marketing and sales rights to sell ten revenue-generating products in Greece and various Eastern European countries.

Disclaimer
The company disclaims any information created by an outside party and endorses only information communicated by its press releases, filings, and Website. This news release contains forward-looking statements that reflect management's current beliefs about the potential for its drug candidates, science, and technology. However, as with any biopharmaceutical under development, there are significant risks and uncertainties in the process of development and regulatory review. There are no guarantees that products will prove to be commercially successful. For additional information about the factors that affect the company's business, please read the company's latest Form 10-K filed April 13, 2007. The company undertakes no duty to update forward-looking statements.

Contact:
The Investor Relations Group
Investor Relations:
Adam Holdsworth
Erica Ruderman
Rachel Colgate
212-825-3210

Samaritan Pharmaceuticals, Inc.
Kristi Eads
702-735-7001

###
Contact Information
Samaritan Pharmaceuticals
Tom Vosicky
702-735-7001
Contact
www.samaritanpharma.com

Click here to view the list of recent Press Releases from Samaritan Pharmaceuticals
Promote Your Business